Precigen
PGEN
#5128
Rank
C$2.14 B
Marketcap
C$6.07
Share price
6.61%
Change (1 day)
353.25%
Change (1 year)

Earnings for Precigen (PGEN)

Earnings in 2025 (TTM): -C$0.35 Billion

According to Precigen's latest financial reports the company's current earnings are C$6.3 Million. In 2024 the company made an earning of -C$0.18 Billion a decrease over its 2023 earnings that were of -C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Precigen from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.35 Billion97.63%
2024 -C$0.18 Billion32.86%
2023 -C$0.14 Billion20.5%
2022 -C$0.11 Billion-23.33%
2021 -C$0.15 Billion60.11%
2020 -C$89.18 Million-65.1%
2019 -C$0.26 Billion-65.19%
2018 -C$0.74 Billion313.44%
2017 -C$0.18 Billion-33.2%
2016 -C$0.27 Billion123.22%
2015 -C$0.12 Billion1.47%
2014 -C$0.12 Billion109.54%
2013 -C$56.01 Million-50.04%
2012 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novocure
NVCR
-C$0.18 Billion-48.56% Jersey
Novavax
NVAX
C$0.51 B-251.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
-C$3.41 Million-98.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-C$0.11 Billion-70.41%๐Ÿ‡ฌ๐Ÿ‡ง UK